trial · primary record
OpRegen
Age-Related Macular Degeneration
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2031-01-31 |
| Primary endpoint | Percentage of Participants With Treatment Emergent Adverse Events |
| Registry ID | NCT02286089 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:12.076Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02286089
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.